Peter G. Traber
2014 - Galectin Therapeutics
In 2014, Peter G. Traber earned a total compensation of $2.3M as Chief Executive Officer & President at Galectin Therapeutics, a 268% increase compared to previous year.
Compensation breakdown
| Bonus | $213,400 |
|---|---|
| Option Awards | $1,512,150 |
| Salary | $485,000 |
| Other | $41,502 |
| Total | $2,252,052 |
Traber received $1.5M in option awards, accounting for 67% of the total pay in 2014.
Traber also received $213.4K in bonus, $485K in salary and $41.5K in other compensation.
Rankings
In 2014, Peter G. Traber's compensation ranked 4,045th out of 13,032 executives tracked by ExecPay. In other words, Traber earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,045 out of 13,032 | 69th |
Division Manufacturing | 1,431 out of 4,965 | 71st |
Major group Chemicals And Allied Products | 465 out of 1,690 | 73rd |
Industry group Drugs | 360 out of 1,369 | 74th |
Industry Pharmaceutical Preparations | 288 out of 1,042 | 72nd |
Source: SEC filing on November 7, 2017.
Traber's colleagues
We found three more compensation records of executives who worked with Peter G. Traber at Galectin Therapeutics in 2014.